TREA

79382428 - MYOSCREEN

Follow

Information

  • Trademark
  • 79382428
  • Serial Number
    79382428
  • Registration Number
    7691258
  • Filing Date
    May 26, 2023
    2 years ago
  • Registration Date
    February 18, 2025
    5 months ago
  • Transaction Date
    May 19, 2025
    2 months ago
  • Status Date
    February 18, 2025
    5 months ago
  • Published for Opposition Date
    December 31, 2024
    7 months ago
  • Location Date
    February 17, 2025
    5 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    REID, CAILE
  • Attorney Docket Number
    19636-010067
    Attorney Name
    Steven J. Solomon
  • Owners
Information
Mark Drawing Code
4
Mark Identification
MYOSCREEN
Case File Statements
  • GS0091: Quality control and testing devices namely culture plates to test and conduct quality control in the field of biology, biotechnology and pharmacy; downloadable software for the collection, processing and analysis of data in the field of biotechnology and pharmacy; scientific laboratory instruments, namely computer hardware and downloadable software for data analysis, database management, data processing, in the field of life science research and the pharmaceutical industry market and diagnostics
  • GS0051: Pharmaceutical products, namely pharmaceutical preparations for the prevention and the treatment of muscle dysfunction associated diseases, muscle dystrophies, muscle metabolic diseases, muscle atrophy associated diseases, sarcopenia, cancer, cachexia, obesity, diabetes and cardiovascular diseases, renal diseases, nephropathies, neuropathies, retinopathies, neurodegenerative, psychiatric and cognitive diseases, metabolic diseases, inflammatory diseases; veterinary products, namely veterinary preparations for the prevention and the treatment of muscle dysfunction associated diseases, muscle dystrophies, muscle metabolic diseases, muscle atrophy associated diseases, sarcopenia, cancer, cachexia, obesity, diabetes and cardiovascular diseases, renal diseases, nephropathies, neuropathies, retinopathies, neurodegenerative, psychiatric and cognitive diseases, metabolic diseases, inflammatory diseases; sanitary preparations for medical use; chemical and biological preparations for medical use, namely pharmaceutical preparations for the prevention and the treatment of muscle dysfunction associated diseases, muscle dystrophies, muscle metabolic diseases, muscle atrophy associated diseases, sarcopenia, cancer, cachexia, obesity, diabetes and cardiovascular diseases, renal diseases, nephropathies, neuropathies, retinopathies, neurodegenerative, psychiatric and cognitive diseases, metabolic diseases, inflammatory diseases; chemical and biological preparations for pharmaceutical use for the prevention and the treatment of muscle dysfunction associated diseases, muscle dystrophies, muscle metabolic diseases, muscle atrophy associated diseases, sarcopenia, cancer, cachexia, obesity, diabetes and cardiovascular diseases, renal diseases, nephropathies, neuropathies, retinopathies, neurodegenerative, psychiatric and cognitive diseases, metabolic diseases, inflammatory diseases, and biological preparations for pharmaceutical use being biological preparations for use in cell cultures for medical purposes
  • GS0421: Medical, biotechnological, and pharmaceutical research; research and development of chemical, biological and scientific products and materials in the biological, biotechnological, medical, diagnostic and pharmaceutical fields; scientific research, advisory and information services in the medical, biotechnological, pharmaceutical, diagnostic, technological and industrial fields; design and development of computers, software and computer platforms; technical testing namely technological testing in the scientific, biological, biotechnological and medical fields and quality control services of goods and services; advisory services with respect to quality testing, technical testing namely, technological testing in the scientific, biological, biotechnological and medical fields, and scientific research advisory services with respect to scientific and medical clinical trials; services for scientific development and analysis of cell tests; scientific and medical research and development of products and services in the field of imaging, in the scientific, biological, biochemical, molecular-biology, biotechnological and medical fields; Scientific interpretation and analysis of data by imaging in the scientific, biological, biochemical, molecular-biology, biotechnological and medical fields; diagnostic and industrial research in the biological, biotechnological and medical fields
Case File Event Statements
  • 11/2/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 11/3/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/7/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/20/2024 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/2/2024 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/1/2024 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/25/2024 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/25/2024 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 4/16/2024 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 9/23/2024 - 10 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/23/2024 - 10 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/23/2024 - 10 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/22/2024 - 9 months ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 10/22/2024 - 9 months ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 10/22/2024 - 9 months ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 10/22/2024 - 9 months ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 10/22/2024 - 9 months ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/25/2024 - 7 months ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/31/2024 - 7 months ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/31/2024 - 7 months ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/18/2025 - 5 months ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/18/2025 - 5 months ago
    22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 5/18/2025 - 2 months ago
    26 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/19/2025 - 3 months ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 3/31/2025 - 4 months ago
    24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 3/31/2025 - 4 months ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR